Patents by Inventor Pandurang Zaware

Pandurang Zaware has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL COMPOUNDS SUITABLE FOR THE TREATMENT OF DYSLIPIDEMIA
    Publication number: 20230089247
    Abstract: The present invention relates to compounds of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation The present invention is directed towards compounds which can be useful in treating diseases such as Hyperlipidemia and also have a beneficial effect on lowering cholesterol.
    Type: Application
    Filed: December 24, 2020
    Publication date: March 23, 2023
    Inventors: Rajiv SHARMA, Sanjay KUMAR, Harikishore PINGALI, Suresh POLA, Pankaj MAKADIA, Prashant DESHMUKH, Pandurang ZAWARE, Kiran SHAH
  • NOVEL SALTS, CRYSTALLINE FORMS AND PREMIX OF HYPOLIPIDEMIC AGENT
    Publication number: 20220169603
    Abstract: Present invention relates to novel salts of saroglitazar and certain polymorphic forms of saroglitazar salts. Invention provides process for the preparation of novel salts and polymorphic forms of saroglitazar. Invention also provides novel co-precipitants or premixes of saroglitazar with pharmaceutically acceptable excipients/secondary therapeutic agent and process for the preparing same.
    Type: Application
    Filed: March 11, 2020
    Publication date: June 2, 2022
    Inventors: Rajiv Sharma, Sanjay Kumar, Brijesh Kumar Srivastava, Harikishore Pingali, Ranjeet Nair, Kalpesh Shah, Pandurang Zaware, Manoj Patel, Kamal Dave
  • GPR 119 agonists
    Patent number: 8785463
    Abstract: The present invention relates to novel GPR 119 agonists of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation.
    Type: Grant
    Filed: October 5, 2011
    Date of Patent: July 22, 2014
    Assignee: Cadila Healthcare Limited
    Inventors: Harikishore Pingali, Pandurang Zaware
  • GPR 119 agonists
    Patent number: 8772302
    Abstract: The present invention relates to novel GPR 119 agonists of the general Formula (I), their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, enantiomers, stereoisomers, and polymorphs. The invention also relates to processes for the preparation of the compounds of the invention, pharmaceutical compositions containing the compounds and to methods for treating one or both of diabetes and obesity using the compounds of the invention. The present invention is directed to G-protein coupled receptor (GPCR) agonists that are useful for the treatment of obesity, diabetes and related metabolic disorders.
    Type: Grant
    Filed: June 17, 2010
    Date of Patent: July 8, 2014
    Assignee: Cadila Healthcare Limited
    Inventors: Harikishore Pingali, Pandurang Zaware, Mukul Jain
  • Oxime derivatives
    Patent number: 8742117
    Abstract: The present invention relates to novel oxime derivatives of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation.
    Type: Grant
    Filed: December 22, 2009
    Date of Patent: June 3, 2014
    Assignee: Cadila Healthcare Limited
    Inventors: Harikishore Pingali, Mukul R. Jain, Pandurang Zaware
  • NOVEL GPR 119 AGONISTS
    Publication number: 20130252980
    Abstract: The present invention relates to novel GPR 119 agonists of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation.
    Type: Application
    Filed: October 5, 2011
    Publication date: September 26, 2013
    Applicant: Cadila Healthcare Limited
    Inventors: Harikishore Pingali, Pandurang Zaware
  • NOVEL GPR 119 AGONISTS
    Publication number: 20120122905
    Abstract: The present invention relates to novel GPR 119 agonists of the general Formula (I), their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, enantiomers, stereoisomers, and polymorphs. The invention also relates to processes for the preparation of the compounds of the invention, pharmaceutical compositions containing the compounds and to methods for treating one or both of diabetes and obesity using the compounds of the invention. The present invention is directed to G-protein coupled receptor (GPCR) agonists that are useful for the treatment of obesity, diabetes and related metabolic disorders.
    Type: Application
    Filed: June 17, 2010
    Publication date: May 17, 2012
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Harikishore Pingali, Pandurang Zaware, Mukul Jain
  • NOVEL OXIME DERIVATIVES
    Publication number: 20120028996
    Abstract: The present invention relates to novel oxime derivatives of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation.
    Type: Application
    Filed: December 22, 2009
    Publication date: February 2, 2012
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Harikishore Pingali, Mukul R. Jain, Pandurang Zaware